PermeaDerm加速部分厚度烧伤早期创面愈合:多中心随机对照试验
该多中心随机对照试验纳入184例中国部分厚度烧伤患者,1:1随机接受PermeaDerm生物合成创面基质或猪脱细胞真皮基质(ADM)治疗。主要终点为第14天(浅II度)或第21天(深II度)完全再上皮化比例,PermeaDerm不劣于ADM;第7天PermeaDerm组早期完全再上皮化比例和创面面积缩小速率显著更高,完全再上皮化时间缩短约3天,安全性与ADM相当。
要点
- PermeaDerm在第7天显著提高浅II度和深II度烧伤的早期完全再上皮化比例。
- PermeaDerm缩短完全再上皮化时间约3天,且疼痛评分和并发症发生率与ADM相似。
- PermeaDerm在易用性、创面可视性和移除方面更优,可作为部分厚度烧伤的临床替代选择。
核心结论
- PermeaDerm加速部分厚度烧伤早期创面愈合并缩短完全再上皮化时间,安全性特征与ADM相当。
研究设计与样本
- 多中心随机对照试验,共纳入184例中国部分厚度烧伤患者,1:1随机接受PermeaDerm或猪脱细胞真皮基质(ADM)治疗。
主要发现
- 第7天浅II度烧伤早期完全再上皮化比例PermeaDerm组为55.6%(20/36),ADM组为27.0%(10/37),p=0.012。
- 第7天深II度烧伤早期完全再上皮化比例PermeaDerm组为37.2%(19/51),ADM组为12.7%(7/55),p=0.005。
- 第7天浅II度烧伤创面面积缩小速率中位数PermeaDerm组为2.41 cm²/day(IQR 0.86-5.07),ADM组为1.05 cm²/day(IQR 0.34-3.01),p=0.034。
- 第7天深II度烧伤创面面积缩小速率中位数PermeaDerm组为3.50 cm²/day(IQR 1.40-8.02),ADM组为1.78 cm²/day(IQR 0.85-4.40),p=0.021。
- 完全再上皮化中位时间浅II度烧伤PermeaDerm组为7.00天(IQR 6-10.25),ADM组为10.00天(IQR 7-12.75),p=0.016;深II度烧伤PermeaDerm组为10.00天(IQR 7-13),ADM组为13.00天(IQR 10-15),p=0.003。
关键数值与推荐
- 主要终点为第14天(浅II度烧伤)或第21天(深II度烧伤)完全再上皮化的创面比例,PermeaDerm不劣于ADM。
- 第7天后两组愈合率相当,疼痛评分和并发症发生率相似。
- PermeaDerm在易用性、创面可视性和移除方面更优。
临床怎么用
- 对于部分厚度烧伤,可考虑使用PermeaDerm以加速早期再上皮化并缩短愈合时间。
- PermeaDerm安全性特征与ADM相当,且操作和创面观察更方便。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This multicenter, randomized controlled trial evaluated the safety and efficacy of PermeaDerm, a biosynthetic wound matrix, compared to porcine acellular dermal matrix (ADM) for the treatment of partial-thickness burns in Chinese patients. METHODS: A total of 184 patients were enrolled and randomized 1:1 to receive either PermeaDerm or ADM across the four Chinese centers. The primary endpoint was the proportion of wounds that achieved complete re-epithelialization by day 14 (superficial partial-thickness burns) or 21 (deep partial-thickness burns). The secondary endpoints included complete re-epithelialization over time, wound area reduction rate (cm2/day), time to complete re-epithelialization, pain scores, device performance, and incidence of complications. RESULTS: PermeaDerm was non-inferior to ADM for the primary endpoint. On day 7, significantly more wounds treated with PermeaDerm achieved early complete re-epithelialization for superficial partial-thickness burns (55.6% [20/36] vs. 27.0% [10/37], p = 0.012) and deep partial-thickness burns (37.2% [19/51] vs. 12.7% [7/55], p = 0.005). The median wound area reduction rate at day 7 was also significantly higher with PermeaDerm for both superficial partial-thickness burns (2.41 cm²/day (IQR 0.86-5.07) vs. 1.05 cm²/day (IQR 0.34-3.01), p = 0.034) and deep partial-thickness burns (3.50 cm²/day (IQR 1.40-8.02) vs. 1.78 cm²/day (IQR 0.85-4.40), p = 0.021). After day 7, the healing rates were comparable between the groups. Median time to complete re-epithelialization was 3 days shorter with PermeaDerm for both superficial (7.00 days (IQR 6-10.25) vs. 10.00 days (IQR 7-12.75), p = 0.016) and deep partial-thickness burns (10.00 days (IQR 7-13) vs. 13.00 days (IQR 10-15), p = 0.003). Pain scores and complication rates were similar between the groups, while PermeaDerm was associated with more favorable ease of application, wound visibility, and removal. CONCLUSION: PermeaDerm accelerates early wound healing and shortens the time to complete re-epithelialization compared with ADM, while maintaining a comparable safety profile. These findings suggest that PermeaDerm may represent a clinically useful alternative for the management of partial-thickness burns.
引用
- Tang H, Chu G, Xiang J, et al. PermeaDerm accelerates early wound healing in partial-thickness burns: A multicenter randomized controlled trial. Burns. 2026. PMID: 42296606. doi:10.1016/j.burns.2026.108060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。